RVL Pharmaceuticals plc Quarterly Common Stock, Shares, Issued from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
RVL Pharmaceuticals plc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2018 to Q2 2023.
  • RVL Pharmaceuticals plc Common Stock, Shares, Issued for the quarter ending June 30, 2023 was 99.4M shares, a 18.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 99.4M +15.8M +18.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 99.3M +15.8M +19% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 99.2M +15.9M +19% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 99.2M +36M +57.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 83.6M +20.8M +33% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 83.5M +20.8M +33.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 83.3M +20.8M +33.2% Dec 31, 2021 10-K 2023-03-20
Q3 2021 63.1M +21.5K +0.03% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 62.8M +4.09M +6.96% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 62.7M +3.82M +6.49% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 62.5M +10.7M +20.6% Dec 31, 2020 10-K 2022-03-30
Q3 2020 63.1M +10.9M +21% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 58.8M +6.24M +11.9% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 58.9M +6.38M +12.1% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 51.8M -673K -1.28% Dec 31, 2019 8-K 2021-09-08
Q3 2019 52.2M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 52.5M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 52.5M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 52.5M Dec 31, 2018 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.